Baxalta's P2P Acquisition

Baxalta raised a round of funding on January 11, 2016. Investors include Shire.

Baxalta (NYSE: BXLT) is a global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology.…

Articles about Baxalta's P2P Acquisition: